Concepedia

Christel R. Brinkmann

CR

Statistics

Publications

14

Citations

1.8K

H-Index

13

Active since

2008

Affiliations

Aarhus University Hospital(Current)

Aarhus University

Ragon Institute of MGH, MIT and Harvard

University of Colorado Denver

Burnet Institute

Christel R. Brinkmann is an author at Aarhus University Hospital specializing in antiretroviral therapy, immunology, and life sciences.

Publications per year

2008–2018

14

Publications

14

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann et al. · The Lancet HIV · 2014 · 641 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

Ole S. Søgaard, Mette E. Graversen, Steffen Leth et al. · PLoS Pathogens · 2015 · 523 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparison of HDAC inhibitors in clinical development

Thomas A. Rasmussen, Ole S. Søgaard, Christel R. Brinkmann et al. · Human Vaccines & Immunotherapeutics · 2013 · 190 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat

Rikke Olesen, Selena Viganó, Thomas A. Rasmussen et al. · Journal of Virology · 2015 · 90 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

The toxicity of bovine α‐lactalbumin made lethal to tumor cells is highly dependent on oleic acid and induces killing in cancer cell lines and noncancer‐derived primary cells

Christel R. Brinkmann, Christian W. Heegaard, Torben E. Petersen et al. · FEBS Journal · 2011 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +14

1–5 of 14